Leena Karttunen

690 total citations
12 papers, 487 citations indexed

About

Leena Karttunen is a scholar working on Genetics, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Leena Karttunen has authored 12 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Cancer Research. Recurrent topics in Leena Karttunen's work include Connective tissue disorders research (10 papers), Protease and Inhibitor Mechanisms (4 papers) and Aortic Disease and Treatment Approaches (3 papers). Leena Karttunen is often cited by papers focused on Connective tissue disorders research (10 papers), Protease and Inhibitor Mechanisms (4 papers) and Aortic Disease and Treatment Approaches (3 papers). Leena Karttunen collaborates with scholars based in Finland, United States and Germany. Leena Karttunen's co-authors include Leena Peltonen, Katariina Kainulainen, Lea Puhakka, Lynn Y. Sakai, Michael Raghunath, John B. Mulliken, Alexandre Irrthum, Laurence M. Boon, Ross Rudolph and Terhi Rantamäki and has published in prestigious journals such as Nucleic Acids Research, Nature Genetics and Genome Research.

In The Last Decade

Leena Karttunen

11 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leena Karttunen Finland 9 305 131 124 123 96 12 487
Richard J. Dahl United States 12 146 0.5× 43 0.3× 155 1.3× 130 1.1× 64 0.7× 16 762
Markus S. Ladewig Germany 11 327 1.1× 44 0.3× 42 0.3× 62 0.5× 33 0.3× 19 547
Sandra Birdsall United Kingdom 12 82 0.3× 73 0.6× 94 0.8× 240 2.0× 51 0.5× 15 488
William S. Tung United States 8 70 0.2× 28 0.2× 82 0.7× 157 1.3× 123 1.3× 12 452
T Pasha United States 11 95 0.3× 31 0.2× 82 0.7× 155 1.3× 127 1.3× 12 678
Helen J. Lawce United States 14 134 0.4× 24 0.2× 56 0.5× 141 1.1× 146 1.5× 31 575
Małgorzata Babińska Poland 12 56 0.2× 43 0.3× 75 0.6× 233 1.9× 41 0.4× 20 394
Sverre Heim Sweden 8 96 0.3× 16 0.1× 103 0.8× 182 1.5× 87 0.9× 9 447
Afsane Arvand United States 8 93 0.3× 89 0.7× 96 0.8× 452 3.7× 18 0.2× 8 770
H. Gadner Austria 9 35 0.1× 50 0.4× 79 0.6× 227 1.8× 39 0.4× 21 510

Countries citing papers authored by Leena Karttunen

Since Specialization
Citations

This map shows the geographic impact of Leena Karttunen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leena Karttunen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leena Karttunen more than expected).

Fields of papers citing papers by Leena Karttunen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leena Karttunen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leena Karttunen. The network helps show where Leena Karttunen may publish in the future.

Co-authorship network of co-authors of Leena Karttunen

This figure shows the co-authorship network connecting the top 25 collaborators of Leena Karttunen. A scholar is included among the top collaborators of Leena Karttunen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leena Karttunen. Leena Karttunen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Boon, Laurence M., Pascal Brouillard, Alexandre Irrthum, et al.. (1999). A Gene for Inherited Cutaneous Venous Anomalies (“Glomangiomas”) Localizes to Chromosome 1p21-22. The American Journal of Human Genetics. 65(1). 125–133. 115 indexed citations
2.
Karttunen, Leena, Miikka Vikkula, Laurence M. Boon, & Björn Olsén. (1999). TIE-2 signalling and venous malformations. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 1 indexed citations
3.
4.
Collod‐Béroud, Gwenaëlle, Christophe Béroud, Lesley C. Adès, et al.. (1997). Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 gene. Nucleic Acids Research. 25(1). 147–150. 25 indexed citations
5.
Rantamäki, Terhi, Leena Karttunen, & Leena Peltonen. (1997). Badly Engineered Fibrillin. Trends in Cardiovascular Medicine. 7(8). 282–288. 5 indexed citations
7.
Karttunen, Leena, et al.. (1996). A Point Mutation Creating an ExtraN-Glycosylation Site in Fibrillin-1 Results in Neonatal Marfan Syndrome. Genomics. 36(3). 468–475. 44 indexed citations
8.
Karttunen, Leena. (1996). Molecular pathogenesis of Marfan syndrome. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 3 indexed citations
9.
Rantamäki, Terhi, et al.. (1995). Prenatal diagnosis of marfan syndrome: Identification of a fibrillin‐1 mutation in chorionic villus sample. Prenatal Diagnosis. 15(12). 1176–1181. 15 indexed citations
10.
Karttunen, Leena, et al.. (1994). A compound-heterozygous Marfan patient: two defective fibrillin alleles result in a lethal phenotype.. PubMed. 55(6). 1083–91. 44 indexed citations
11.
Kainulainen, Katariina, Leena Karttunen, Lea Puhakka, Lynn Y. Sakai, & Leena Peltonen. (1994). Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome. Nature Genetics. 6(1). 64–69. 195 indexed citations
12.
Rantamäki, Terhi, et al.. (1994). DNA Diagnostics of the MarfanSyndrome: Application ofAmplifîable Polymorphie Markers. European Journal of Human Genetics. 2(1). 66–75. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026